Device maker MicroTransponder raises $53 million and more funds to support digital health

Medical device maker MicroTransponder has completed a $53 million Series E funding round led by US Venture Partners.

The capital raise also includes participation from GPG Ventures, Exceller Hunt Ventures, Osage University Partners, Action Potential Venture Capital and Vertical Group. The company said it will use the capital to commercialize the Vivistim vagus nerve stimulator, an implant that aims to improve hand and arm mobility in stroke patients.

“Our investors are energized by MicroTransponder’s vision to enable the treatment of millions of stroke survivors with moderate to severe upper limb impairment. Our goal has always been. is the founding of Vivistim Paired VNS which is the gold standard stroke rehabilitation intervention.Today is the day this therapy can help many stroke survivors get back to daily activities, hobbies and experiences. experiences they love”, CEO and director Richard Foust said in a statement.

Oma Fertility emerged from stealth last week with $37.5 million, including $29 million in equity and another $8.5 million in debt.

Seeds and Series A rounds were led by JAZZ Venture Partners, Root Ventures, Mithril Capital, Global Asset Capital, and Free Solo Ventures. The debt base comes from Silicon Valley Bank. The fertility startup’s first product is to identify the healthiest sperm to improve IVF results.

“Oma Fertility is taking the opportunity to bring cutting-edge cutting-edge technological advancements into the fertility space, meeting the needs of rising infertility rates,” said Gurjeet Singh, Co-Founder and CEO said in a statement. “Our mission is to improve outcomes for more families facing fertility problems, and we strive to create a place that is accessible to everyone who wants to have a baby. with the most successful and advanced fertility treatments.”

Payer-focused healthcare data startup Abacus Insights has raised $28 million in Series C funding, bringing its total raised to $81 million.

The round was led by MultiPlan Corporation with participation from Blue Venture Fund, CRV, .406 Ventures, Horizon Healthcare Services Inc. and Echo Health Ventures. Raised abacus $35 million in Series B funding in 2020.

It plans to use the investment to grow its business, improve its platform, and hire more staff.

“This new funding validates our company’s mission to help health plans unleash health data,” CEO and founder, Dr. Minal Patel, said in a statement. Father. “Doing so helps consumers make better health choices and doctors make more informed treatment decisions. Payers also use the platform to drive efficiencies in their business operations. We are proud to partner with MultiPlan because of their leadership position in data and analytics serving nearly every payer in the country.”

Self-pay wellness marketplace Sesame has raised $27 million in a Series B round led by GV.

Virgin Group, TeleSoft Partners, FMZ Ventures, General Catalyst, Industry Ventures, Coerative Capital, Giant Ventures and Alumni Ventures Group also participated in the capital raise. Sesame plans to use the capital to grow the startup and launch its subscription program at a beta stage.

Cathy Friedman, executive venture partner at GV, said: “Sesame provides greater access to health care to a meaningful percentage of the population, and we are inspired by The company’s mission is to promote better patient outcomes for underserved communities,” Cathy Friedman, executive venture partner at GV, said in a statement.

“Sesame offers an exciting opportunity to grow a dynamic market on a scale unlike any other in the current US healthcare ecosystem. We are excited to partner with David Goldhill and the entire Sesame team as they move into this next phase of growth.”

Source link


News5h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button